Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Paclitaxel in Advanced or Recurrent Head and Neck Cancer
NCT00855764Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Oct 2005
- Primary completion
- Oct 2006
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection in head and neck cancer (HNC), sponsored by Bristol Myers Squibb. Started Oct 2005; status: completed.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT00855764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00855764.